A phase 1, open-label, dose-escalation study of SNX-5422 plus carboplatin and paclitaxel in subjects with advanced lung cancers.

被引：0
|
作者：
Gutierrez, Martin
Giaccone, Giuseppe
Harper, Harry D.
Liu, Stephen V.
Fang, Bruno
Ruiz, Jimmy
Hinson, James M.
Orlemans, Everardus Otto
Drilon, Alexander E.
机构：
[1] Hackensack Univ, Med Ctr, Reg Canc Care Associates, John Theurer Canc Ctr, Hackensack, NJ USA
[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Reg Canc Care Associates LLC, East Brunswick, NJ USA
[4] Wake Forest, Ctr Comprehens Canc, Winston Salem, NC USA
[5] Unicorn Pharma Consulting, Nashville, TN USA
[6] Esanex Inc, Indianapolis, IN USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19033
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies
    Lubner, Sam Joseph
    Mullvain, Jacqueline
    Perlman, Scott
    Pishvaian, Michael
    Mortimer, Joanne
    Oliver, Katherine
    Heideman, Jennifer
    Hall, Lance
    Weichert, Jamey
    Liu, Glenn
    CANCER INVESTIGATION, 2015, 33 (10) : 483 - 489
  • [32] A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Yanagitani, Noriko
    Imai, Hisao
    Utsugi, Mitsuyoshi
    Shimizu, Yasuo
    Iijima, Hironobu
    Tomizawa, Yoshio
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Saito, Ryusei
    Mori, Masatomo
    ANTI-CANCER DRUGS, 2007, 18 (04) : 471 - 476
  • [33] A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of Sgr-1505 As Monotherapy in Subjects with Mature B-Cell Malignancies
    Olszewski, Adam
    Kahn, David
    Yoo, Brian
    Tan, Joanne B. L.
    Gupta, Vipul K.
    Schuck, Edgar
    Nie, Zhe
    Krilov, Goran
    Wright, D. Hamish
    Weiss, Daniel
    Lachowicz, Jean
    Akinsanya, Karen
    Yin, Wu
    BLOOD, 2023, 142
  • [34] A Phase 1, Open-label, Dose-escalation Study of Oral Administration of the Investigational Agent MLN0128 in Combination with Paclitaxel (P) in Patients (pts) with Advanced Solid Malignancies
    Burris, H.
    Hart, L.
    Kurkjian, C.
    Berk, G.
    Lipman, P.
    Patel, C.
    Rommel, C.
    Martin, M.
    Infante, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 186 - 186
  • [35] A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma
    Zonder, Jeffrey A.
    Mohrbacher, Ann F.
    Singhal, Seema
    van Rhee, Frits
    Bensinger, William I.
    Ding, Han
    Fry, John
    Afar, Daniel E. H.
    Singhal, Anil K.
    BLOOD, 2012, 120 (03) : 552 - 559
  • [36] Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers
    Cohen, Fredric
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 87 - 94
  • [37] Open-label dose-escalation study of oral 1-octanol in patients with essential tremor
    Shill, HA
    Bushara, KO
    Mari, Z
    Reich, M
    Hallett, M
    NEUROLOGY, 2004, 62 (12) : 2320 - 2322
  • [38] A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas
    Lin, Chia-Chi
    Arkenau, Hendrik-Tobias
    Lu, Sharon
    Sachdev, Jasgit
    de Castro Carpeno, Javier
    Mita, Monica
    Dziadziuszko, Rafal
    Su, Wu-Chou
    Bobilev, Dmitri
    Hughes, Lorraine
    Chan, Jian
    Zhang, Zhi-Yi
    Weiss, Glen J.
    BRITISH JOURNAL OF CANCER, 2019, 121 (02) : 131 - 138
  • [39] A phase Ia/Ib, open-label, dose-escalation study of the TRAILR2 agonist BI 905711 in combination with chemotherapy in patients with advanced gastrointestinal cancers
    Kopetz, S.
    Van Cutsem, E.
    Kuboki, Y.
    Johnson, B.
    Katakabe, T.
    Geng, J.
    Archuadze, S.
    Shen, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S293 - S294
  • [40] Phase 1/2a, open-label, dose-escalation and safety study of APC-100 in men with advanced prostate cancer.
    Kyriakopoulos, Christos
    Heath, Elisabeth I.
    Eickhoff, Jens C.
    Kolesar, Jill
    Yayehyirad, Mulusew
    Moll, Thomas
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345